Tadeusz Robak

Tadeusz Robak

Medical University of Lodz - Lodz / Poland
Others
AD Scientific Index ID: 4664044
Uniwersytet Medyczny w Łodzi
person_outline Tadeusz Robak's MOST POPULAR ARTICLES
1-) Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemiaJC Byrd, JR Brown, S O\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'Brien, JC Barrientos, NE Kay, NM Reddy, ...New England Journal of Medicine 371 (3), 213-223, 201419122014
2-) Ibrutinib as initial therapy for patients with chronic lymphocytic leukemiaJA Burger, A Tedeschi, PM Barr, T Robak, C Owen, P Ghia, O Bairey, ...New England Journal of Medicine 373 (25), 2425-2437, 201516912015
3-) iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLLM Hallek, BD Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, ...Blood, The Journal of the American Society of Hematology 131 (25), 2745-2760, 201815782018
4-) Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority studyP Moreau, H Pylypenko, S Grosicki, I Karamanesht, X Leleu, ...The lancet oncology 12 (5), 431-440, 201112132011
5-) Venetoclax–rituximab in relapsed or refractory chronic lymphocytic leukemiaJF Seymour, TJ Kipps, B Eichhorst, P Hillmen, J D’Rozario, S Assouline, ...New England Journal of Medicine 378 (12), 1107-1120, 201810072018